Fish oil supplementation as well as consumption of foods rich in omega-3 may increase women’s chances of conception by lowering the risk of pregnancy loss, a study has found. On the other hand, in men, omega-3 intake may improve semen quality.
Men who are born small for gestational age (SGA) or with low birthweight (LBW) may be at a disadvantage when it comes to fertility or the prospect of becoming biological fathers, and this becomes more evident as men get older, according to a study.
Infertile men are at higher risk of death, especially those with the most severe form of infertility, although the overall risk is small and lower than that seen in the general population, a study reports.
Assoc Prof. Darren Poon, Assoc Prof. Edmund Chiong,
14 Jan 2021
Metastatic hormone-sensitive prostate cancer (mHSPC) refers to the condition whereby patients have metastatic prostate cancer and no prior hormonal therapy or androgen deprivation therapy (ADT). Typically, patients with mHSPC have been treated with ADT alone, following which, the overwhelming majority develop castration resistance over time and head towards eventual mortality. In recent years, the publication of various landmark trials has prompted dramatic changes in the mHSPC treatment landscape, and had favourably impacted overall survival (OS) in these patients. At a recent webinar, A/Prof Darren Poon, Honorary Consultant in Clinical Oncology, Hong Kong Sanatorium & Hospital, and Honorary Clinical Associate Professor, Department of Clinical Oncology, The Chinese University of Hong Kong, reviewed treatment options in mHSPC, while A/Prof Edmund Chiong, Head and Senior Consultant, Department of Urology, National University Hospital, Singapore, presented a case which was discussed by an esteemed panel of experts. This webinar was jointly organized by the Singapore Society of Oncology and the Singapore Urological Association, and supported by Astellas.